Market Place
Sourcing Support
Overland ADCT BioPharma Begins Dosing in China with ZYNLONTA in PIII trial
11 Jul 2022 //
BUSINESSWIRE
Overland Pharmaceuticals Appoints Dr. Xun Liu as Chief Technology Officer
03 Mar 2022 //
BIOSPECTRUMASIA
Effort to repeat key cancer biology experiments to improve replicability
07 Dec 2021 //
PRNEWSWIRE
ADCT BioPharma Initiates Dosing in Phase 2 of ZYNLONTA for DLBCL
29 Sep 2021 //
BUSINESSWIRE
Overland Pharmaceuticals Appoints Roger Luo, Ph.D. as Chief Development Officer
02 Aug 2021 //
BUSINESS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.